Skip to main content

CCTG Connection



Published:
Category: Group updates
Trial-specific DSMC Summary Reports

Trial-specific DSMC Summary Reports are now posted on trial websites. Single-study centres participating on these trials should download these reports and submit them to their Research Ethics Boards if required by local policy. Trials currently under CCTG's DSMC oversight include:

 

Read More

Published:
Category: Group updates
 new patient representative Tracey Kitz

Join us in welcoming a new patient representative, Tracey Kitz who will be supporting the Hematology Committee.

Tracy Kitz is an optometrist living in Edmonton, Alberta, who dedicates herself to understanding and meeting the needs of her patients every day. In 2009, her mother was diagnosed with multiple myeloma and underwent surgery, chemotherapy, and radiation, followed by a stem cell transplant in 2014. 

Read More

Published:
Category: Publications
CCTG MA.40 FINER clinical trial

The CCTG MA.40 (FINER) clinical trial, is a double-blind placebo controlled randomized phase III trial of fulvestrant and ipatasertib as treatment for advanced HER-2 negative and estrogen receptor positive (ER+) breast cancer following progression on first line CDK 4/6 inhibitor and aromatase inhibitor.

Read More

Published:
Category: Publications
Publication: Hematology guidence and MA21 substudy
Two publications - one for Hematology guidance for measurable/minimal residual disease (MRD) and a Ma21 sub-study around insomnia and how it affects the immune system. Read More

Published:
Category: Publications
HE1 awarded 2024 Till and McCulloch Paper of the year
The HE1 paper published in The Lancet Oncology won the "2024 Princess Margaret Cancer Centre Till and McCulloch Paper of the year (Clinical)" award recognizing outstanding clinical research in the field of oncology, led by a researcher at Princess Margaret Cancer Centre. The Till & McCulloch Award is in honour of Canadian scientists James Till and Ernest McCulloch, whose pioneering work established the field of stem cell research. Read More

Published:
Category: Publications
The CO21 CHALLENGE trial results

In a world-first clinical trial, researchers working with the Canadian Cancer Trials Group (CCTG) have demonstrated that a structured exercise program significantly improves survival for colon cancer patients by reducing the risk of disease recurrence and new primary cancers.

Read More



Published:
Category: Group updates
CCTG at 2025 ASCO Annual Meeting

The ASCO 2025 Annual Meeting, is fast approaching and will be held from May 30 to June 3 in Chicago, Illinois -- This year the theme is of "Driving Knowledge to Action: Building a Better Future". This meeting will feature many CCTG trials and research so please see the list below to ensure you do not miss the oral presentations or poster presentations, showcasing the latest in CCTG research and clinical trial results.

 

Read More

Published:
Category: Group updates
2026 CCTG Annual Spring Meeting of Participants
Don't forget to mark your calendars and save the date for the next CCTG Spring Meeting which will be Friday, April 24 – Sunday, April 26, 2026 at the Chelsea Hotel in Toronto. Read More